Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2015

01-11-2015 | Original Article

Seasonal Variation in Flares of Intestinal Behçet’s Disease

Authors: Jin Ha Lee, Jae Hee Cheon, Sung Pil Hong, Tae Il Kim, Won Ho Kim

Published in: Digestive Diseases and Sciences | Issue 11/2015

Login to get access

Abstract

Background

There have been numerous investigations into the seasonality of several autoimmune diseases and inflammatory bowel disease in an effort to better understand the epidemiology and pathogenesis of these conditions. However, the relationship between the season and disease activity of intestinal Behçet’s disease has not been investigated.

Aims

This study aimed to evaluate the seasonal pattern of exacerbations of intestinal Behçet’s disease.

Methods

We evaluated 268 consecutive patients with intestinal Behçet’s disease who were diagnosed and treated between November 1990 and March 2010 at Severance Hospital, Yonsei University, Seoul, Korea. Patient demographics, onset of symptoms, total number of relapses, and the month of each relapse were recorded. The relationship between the season and flares of intestinal Behçet’s disease was analyzed.

Results

A total of 339 relapses occurred in 142 patients (53 %). The median age at diagnosis was 39 (10–73) years; the median follow-up duration was 74 (7–372) months. The peak seasons for relapse were spring and autumn, especially the months of May and September (p value <0.001). Compared with winter, spring and autumn had higher rates of flares (HR 1.92 and 1.91, respectively, p value <0.001).

Conclusions

In this study, intestinal Behçet’s disease demonstrated a biphasic pattern (peaks in spring and autumn) in exacerbations of disease, suggesting that seasonal or exogenous factors may be involved in the flares of intestinal Behçet’s disease.
Literature
1.
go back to reference Kasahara Y, Tanaka S, Nishino M, et al. Intestinal involvement in Behcet’s disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum. 1981;24:103–106.CrossRefPubMed Kasahara Y, Tanaka S, Nishino M, et al. Intestinal involvement in Behcet’s disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum. 1981;24:103–106.CrossRefPubMed
3.
go back to reference Schlesinger N, Schlesinger M, Seshan SV. Seasonal variation of lupus nephritis: high prevalence of class V lupus nephritis during the winter and spring. J Rheumatol. 2005;32:1053–1057.PubMed Schlesinger N, Schlesinger M, Seshan SV. Seasonal variation of lupus nephritis: high prevalence of class V lupus nephritis during the winter and spring. J Rheumatol. 2005;32:1053–1057.PubMed
4.
go back to reference Hawley DJ, Wolfe F, Lue FA, et al. Seasonal symptom severity in patients with rheumatic diseases: a study of 1424 patients. J Rheumatol. 2001;28:1900–1909.PubMed Hawley DJ, Wolfe F, Lue FA, et al. Seasonal symptom severity in patients with rheumatic diseases: a study of 1424 patients. J Rheumatol. 2001;28:1900–1909.PubMed
7.
go back to reference Zeng L, Anderson FH. Seasonal change in the exacerbations of Crohn’s disease. Scand J Gastroenterol. 1996;31:79–82.CrossRefPubMed Zeng L, Anderson FH. Seasonal change in the exacerbations of Crohn’s disease. Scand J Gastroenterol. 1996;31:79–82.CrossRefPubMed
9.
go back to reference Angelucci E, Cocco A, Cesarini M, et al. Monthly and seasonal birth patterns and the occurrence of Crohn’s disease. Am J Gastroenterol. 2009;104:1608–1609.CrossRefPubMed Angelucci E, Cocco A, Cesarini M, et al. Monthly and seasonal birth patterns and the occurrence of Crohn’s disease. Am J Gastroenterol. 2009;104:1608–1609.CrossRefPubMed
10.
go back to reference Aratari A, Papi C, Galletti B, et al. Seasonal variations in onset of symptoms in Crohn’s disease. Dig Liver Dis. 2006;38:319–323.CrossRefPubMed Aratari A, Papi C, Galletti B, et al. Seasonal variations in onset of symptoms in Crohn’s disease. Dig Liver Dis. 2006;38:319–323.CrossRefPubMed
11.
go back to reference Lewis JD, Aberra FN, Lichtenstein GR, et al. Seasonal variation in flares of inflammatory bowel disease. Gastroenterology. 2004;126:665–673.CrossRefPubMed Lewis JD, Aberra FN, Lichtenstein GR, et al. Seasonal variation in flares of inflammatory bowel disease. Gastroenterology. 2004;126:665–673.CrossRefPubMed
12.
go back to reference Vergara M, Fraga X, Casellas F, et al. Seasonal influence in exacerbations of inflammatory bowel disease. Rev Esp Enferm Dig. 1997;89:357–366.PubMed Vergara M, Fraga X, Casellas F, et al. Seasonal influence in exacerbations of inflammatory bowel disease. Rev Esp Enferm Dig. 1997;89:357–366.PubMed
13.
go back to reference Jung YS, Song CS, Kim ER, et al. Seasonal variation in months of birth and symptom flares in Korean patients with inflammatory bowel disease. Gut Liver. 2013;7:661–667.PubMedCentralCrossRefPubMed Jung YS, Song CS, Kim ER, et al. Seasonal variation in months of birth and symptom flares in Korean patients with inflammatory bowel disease. Gut Liver. 2013;7:661–667.PubMedCentralCrossRefPubMed
14.
15.
go back to reference Cheon JH, Kim ES, Shin SJ, et al. Development and validation of novel diagnostic criteria for intestinal Behcet’s disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009;104:2492–2499.CrossRefPubMed Cheon JH, Kim ES, Shin SJ, et al. Development and validation of novel diagnostic criteria for intestinal Behcet’s disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009;104:2492–2499.CrossRefPubMed
16.
go back to reference Cheon JH, Kim WH. An update on the diagnosis, treatment, and prognosis of intestinal Behcet’s disease. Curr Opin Rheumatol. 2015;27:24–31.CrossRefPubMed Cheon JH, Kim WH. An update on the diagnosis, treatment, and prognosis of intestinal Behcet’s disease. Curr Opin Rheumatol. 2015;27:24–31.CrossRefPubMed
17.
go back to reference Krause I, Shraga I, Molad Y, et al. Seasons of the year and activity of SLE and Behcet’s disease. Scand J Rheumatol. 1997;26:435–439.CrossRefPubMed Krause I, Shraga I, Molad Y, et al. Seasons of the year and activity of SLE and Behcet’s disease. Scand J Rheumatol. 1997;26:435–439.CrossRefPubMed
18.
19.
go back to reference Tysk C, Jarnerot G. Seasonal variation in exacerbations of ulcerative colitis. Scand J Gastroenterol. 1993;28:95–96.CrossRefPubMed Tysk C, Jarnerot G. Seasonal variation in exacerbations of ulcerative colitis. Scand J Gastroenterol. 1993;28:95–96.CrossRefPubMed
20.
go back to reference Karamanolis DG, Delis KC, Papatheodoridis GV, et al. Seasonal variation in exacerbations of ulcerative colitis. Hepatogastroenterology. 1997;44:1334–1338.PubMed Karamanolis DG, Delis KC, Papatheodoridis GV, et al. Seasonal variation in exacerbations of ulcerative colitis. Hepatogastroenterology. 1997;44:1334–1338.PubMed
22.
go back to reference Sonnenberg A, Jacobsen SJ, Wasserman IH. Periodicity of hospital admissions for inflammatory bowel disease. Am J Gastroenterol. 1994;89:847–851.PubMed Sonnenberg A, Jacobsen SJ, Wasserman IH. Periodicity of hospital admissions for inflammatory bowel disease. Am J Gastroenterol. 1994;89:847–851.PubMed
23.
go back to reference Bai A, Guo Y, Shen Y, et al. Seasonality in flares and months of births of patients with ulcerative colitis in a Chinese population. Dig Dis Sci. 2009;54:1094–1098.CrossRefPubMed Bai A, Guo Y, Shen Y, et al. Seasonality in flares and months of births of patients with ulcerative colitis in a Chinese population. Dig Dis Sci. 2009;54:1094–1098.CrossRefPubMed
24.
go back to reference Don BA, Goldacre MJ. Absence of seasonality in emergency hospital admissions for inflammatory bowel disease. Lancet. 1984;2:1156–1157.CrossRefPubMed Don BA, Goldacre MJ. Absence of seasonality in emergency hospital admissions for inflammatory bowel disease. Lancet. 1984;2:1156–1157.CrossRefPubMed
25.
go back to reference Soncini M, Triossi O, Leo P, et al. Seasonal patterns of hospital treatment for inflammatory bowel disease in Italy. Digestion. 2006;73:1–8.CrossRefPubMed Soncini M, Triossi O, Leo P, et al. Seasonal patterns of hospital treatment for inflammatory bowel disease in Italy. Digestion. 2006;73:1–8.CrossRefPubMed
26.
go back to reference Lee GJ, Dotson JL, Kappelman MD, et al. Seasonality and pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014;59:25–28.CrossRefPubMed Lee GJ, Dotson JL, Kappelman MD, et al. Seasonality and pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014;59:25–28.CrossRefPubMed
27.
go back to reference Gebhard RL, Greenberg HB, Singh N, et al. Acute viral enteritis and exacerbations of inflammatory bowel disease. Gastroenterology. 1982;83:1207–1209.PubMed Gebhard RL, Greenberg HB, Singh N, et al. Acute viral enteritis and exacerbations of inflammatory bowel disease. Gastroenterology. 1982;83:1207–1209.PubMed
28.
go back to reference Newman A, Lambert JR. Campylobacter jejuni causing flare-up in inflammatory bowel disease. Lancet. 1980;2:919.CrossRefPubMed Newman A, Lambert JR. Campylobacter jejuni causing flare-up in inflammatory bowel disease. Lancet. 1980;2:919.CrossRefPubMed
29.
go back to reference Sonnenberg A. Seasonal variation of enteric infections and inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:955–959.CrossRefPubMed Sonnenberg A. Seasonal variation of enteric infections and inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:955–959.CrossRefPubMed
30.
go back to reference Moore M, Centers for Disease Control. Enteroviral disease in the United States, 1970–1979. J Infect Dis. 1982;146:103–108.CrossRefPubMed Moore M, Centers for Disease Control. Enteroviral disease in the United States, 1970–1979. J Infect Dis. 1982;146:103–108.CrossRefPubMed
32.
go back to reference Kangro HO, Chong SK, Hardiman A, et al. A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease. Gastroenterology. 1990;98:549–553.PubMed Kangro HO, Chong SK, Hardiman A, et al. A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease. Gastroenterology. 1990;98:549–553.PubMed
33.
go back to reference Kim MR, Lee HR, Lee GM. Epidemiology of acute viral respiratory tract infections in Korean children. J Infect. 2000;41:152–158.CrossRefPubMed Kim MR, Lee HR, Lee GM. Epidemiology of acute viral respiratory tract infections in Korean children. J Infect. 2000;41:152–158.CrossRefPubMed
34.
go back to reference Ahn KM, Chung SH, Chung EH, et al. Clinical characteristics of acute viral lower respiratory tract infections in hospitalized children in Seoul, 1996–1998. J Korean Med Sci. 1999;14:405–411.PubMedCentralCrossRefPubMed Ahn KM, Chung SH, Chung EH, et al. Clinical characteristics of acute viral lower respiratory tract infections in hospitalized children in Seoul, 1996–1998. J Korean Med Sci. 1999;14:405–411.PubMedCentralCrossRefPubMed
35.
go back to reference Cantorna MT, Zhu Y, Froicu M, et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80:1717s–1720s.PubMed Cantorna MT, Zhu Y, Froicu M, et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80:1717s–1720s.PubMed
36.
go back to reference Hayes CE, Nashold FE, Spach KM, et al. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003;49:277–300. Hayes CE, Nashold FE, Spach KM, et al. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003;49:277–300.
37.
go back to reference Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl). 2010;88:441–450.CrossRef Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl). 2010;88:441–450.CrossRef
38.
go back to reference Rigby WF, Waugh M, Graziano RF. Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. Blood. 1990;76:189–197.PubMed Rigby WF, Waugh M, Graziano RF. Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. Blood. 1990;76:189–197.PubMed
39.
go back to reference Penna G, Adorini L. 1-α,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000;164:2405–2411.CrossRefPubMed Penna G, Adorini L. 1-α,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000;164:2405–2411.CrossRefPubMed
40.
go back to reference Canning MO, Grotenhuis K, de Wit H, et al. 1-α,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol. 2001;145:351–357.CrossRefPubMed Canning MO, Grotenhuis K, de Wit H, et al. 1-α,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol. 2001;145:351–357.CrossRefPubMed
41.
go back to reference Griffin MD, Lutz WH, Phan VA, et al. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun. 2000;270:701–708.CrossRefPubMed Griffin MD, Lutz WH, Phan VA, et al. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun. 2000;270:701–708.CrossRefPubMed
42.
go back to reference Yap KS, Morand EF. Vitamin D and systemic lupus erythematosus: continued evolution. Int J Rheum Dis. 2015;18:242–249.CrossRefPubMed Yap KS, Morand EF. Vitamin D and systemic lupus erythematosus: continued evolution. Int J Rheum Dis. 2015;18:242–249.CrossRefPubMed
43.
go back to reference Mouli VP, Ananthakrishnan AN. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014;39:125–136.CrossRefPubMed Mouli VP, Ananthakrishnan AN. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014;39:125–136.CrossRefPubMed
44.
go back to reference Rossini M, Maddali Bongi S, La Montagna G, et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther. 2010;12:R216.PubMedCentralCrossRefPubMed Rossini M, Maddali Bongi S, La Montagna G, et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther. 2010;12:R216.PubMedCentralCrossRefPubMed
45.
go back to reference Gatenby P, Lucas R, Swaminathan A. Vitamin D deficiency and risk for rheumatic diseases: an update. Curr Opin Rheumatol. 2013;25:184–191.CrossRefPubMed Gatenby P, Lucas R, Swaminathan A. Vitamin D deficiency and risk for rheumatic diseases: an update. Curr Opin Rheumatol. 2013;25:184–191.CrossRefPubMed
46.
go back to reference Jorgensen SP, Hvas CL, Agnholt J, et al. Active Crohn’s disease is associated with low vitamin D levels. J Crohns Colitis. 2013;7:e407–e413.CrossRefPubMed Jorgensen SP, Hvas CL, Agnholt J, et al. Active Crohn’s disease is associated with low vitamin D levels. J Crohns Colitis. 2013;7:e407–e413.CrossRefPubMed
47.
go back to reference Khabbazi A, Rashtchizadeh N, Ghorbanihaghjo A, et al. The status of serum vitamin D in patients with active Behcet’s disease compared with controls. Int J Rheum Dis. 2014;17:430–434.CrossRefPubMed Khabbazi A, Rashtchizadeh N, Ghorbanihaghjo A, et al. The status of serum vitamin D in patients with active Behcet’s disease compared with controls. Int J Rheum Dis. 2014;17:430–434.CrossRefPubMed
48.
go back to reference Can M, Gunes M, Haliloglu OA, et al. Effect of vitamin D deficiency and replacement on endothelial functions in Behcet’s disease. Clin Exp Rheumatol. 2012;30:S57–S61.PubMed Can M, Gunes M, Haliloglu OA, et al. Effect of vitamin D deficiency and replacement on endothelial functions in Behcet’s disease. Clin Exp Rheumatol. 2012;30:S57–S61.PubMed
49.
go back to reference Kini GP, Young B, Herbison P, et al. Does seasonal level of serum 25-OH vitamin D correlate with the activity of Crohn’s disease? N Z Med J. 2014;127:51–59.PubMed Kini GP, Young B, Herbison P, et al. Does seasonal level of serum 25-OH vitamin D correlate with the activity of Crohn’s disease? N Z Med J. 2014;127:51–59.PubMed
50.
go back to reference Turhanoglu AD, Guler H, Yonden Z, et al. The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatol Int. 2011;31:911–914.CrossRefPubMed Turhanoglu AD, Guler H, Yonden Z, et al. The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatol Int. 2011;31:911–914.CrossRefPubMed
51.
go back to reference Melin A, Wilske J, Ringertz H, et al. Seasonal variations in serum levels of 25-hydroxyvitamin D and parathyroid hormone but no detectable change in femoral neck bone density in an older population with regular outdoor exposure. J Am Geriatr Soc. 2001;49:1190–1196.CrossRefPubMed Melin A, Wilske J, Ringertz H, et al. Seasonal variations in serum levels of 25-hydroxyvitamin D and parathyroid hormone but no detectable change in femoral neck bone density in an older population with regular outdoor exposure. J Am Geriatr Soc. 2001;49:1190–1196.CrossRefPubMed
52.
go back to reference Klenk J, Rapp K, Denkinger MD, et al. Seasonality of vitamin D status in older people in Southern Germany: implications for assessment. Age Ageing. 2013;42:404–408.CrossRefPubMed Klenk J, Rapp K, Denkinger MD, et al. Seasonality of vitamin D status in older people in Southern Germany: implications for assessment. Age Ageing. 2013;42:404–408.CrossRefPubMed
53.
go back to reference Chung IH, Kim HJ, Chung S, et al. Vitamin D deficiency in Korean children: prevalence, risk factors, and the relationship with parathyroid hormone levels. Ann Pediatr Endocrinol Metab. 2014;19:86–90.PubMedCentralCrossRefPubMed Chung IH, Kim HJ, Chung S, et al. Vitamin D deficiency in Korean children: prevalence, risk factors, and the relationship with parathyroid hormone levels. Ann Pediatr Endocrinol Metab. 2014;19:86–90.PubMedCentralCrossRefPubMed
Metadata
Title
Seasonal Variation in Flares of Intestinal Behçet’s Disease
Authors
Jin Ha Lee
Jae Hee Cheon
Sung Pil Hong
Tae Il Kim
Won Ho Kim
Publication date
01-11-2015
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2015
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3863-x

Other articles of this Issue 11/2015

Digestive Diseases and Sciences 11/2015 Go to the issue

GRG PROFILES AND PERSPECTIVES

GRG Profiles: David A. Lieberman

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.